Key result
Patients with left ventricular hypertrophy had a lower midwall ejection fraction compared to controls, demonstrating its utility in detecting systolic dysfunction.
Why the study?
Does midwall ejection fraction measured by 2D speckle tracking echocardiography detect left ventricular systolic dysfunction in patients with left ventricular hypertrophy better than conventional EF?
Cross-Sectional (n=60)
No
Does midwall ejection fraction measured by 2D speckle tracking echocardiography detect left ventricular systolic dysfunction in patients with left ventricular hypertrophy better than conventional EF?
Midwall EF assessed by 2D speckle tracking echocardiography can detect subtle LV systolic dysfunction in patients with LVH that is missed by conventional EF.
Answers are grounded in this paper and cite their sources.
May identify subtle LV systolic dysfunction in LVH missed by conventional EF; leaves open whether it improves risk stratification or outcomes.
BACKGROUND: In patients with left ventricular hypertrophy (LVH), LV midwall fractional shortening (FS) is used as a measure of LV systolic performance that is more physiologically appropriate than conventional FS. For evaluation of LV volume and ejection fraction (EF), 2-dimensional (2D) echocardiography is more accurate than M-mode echocardiography. The purpose of this study was to assess systolic performance by midwall EF using 2D speckle tracking echocardiography (STE). METHODS: Sixty patients were enrolled in the study. Patients were divided into two groups with LVH (n = 30) and without LVH (control group, n = 30). LV systolic function was compared between the two groups and the relationships of left ventricular mass index (LVMI) with LV systolic parameters, including midwall EF, were investigated. RESULTS: Midwall EF in the LVH group was significantly lower than that in the control group (42.8±4.4% vs. 48.1±4.1%, p <0.0001). Midwall FS was also significantly lower in the LVH group (13.4±2.8% vs. 16.1±1.5%, p <0.0001), but EF did not differ significantly between the two groups. There were significant correlations between midwall EF and LVMI (r=0.731, p <0.0001) and between midwall FS and LVMI (r=0.693, p <0.0001), with midwall EF having the higher correlation. CONCLUSIONS: These results show that midwall EF can be determined using 2D STE. Midwall EF can be used to monitor LV systolic dysfunction, which is not possible with conventional EF. Evaluation of midwall EF may allow assessment of new parameters of LV systolic function in patients with LV geometric variability.
No takes yet. Share an insight, caveat, or question.
Yoshikawa et al. (2012) conducted a cross-sectional in Left ventricular hypertrophy (n=60). Left ventricular hypertrophy vs. Without left ventricular hypertrophy was evaluated on Midwall ejection fraction (p=<0.0001). Patients with left ventricular hypertrophy had a lower midwall ejection fraction compared to controls, demonstrating its utility in detecting systolic dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: